White House commission examines research on complementary cancer therapies.
Fritts
M
M
D017326:Clinical Trials, Phase III as Topic; D000529:Complementary Therapies / Q000331:legislation & jurisprudence / Q000592:standards / Q000639:trends; D006801:Humans; D008175:Lung Neoplasms / Q000628:therapy; D008297:Male; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000628:therapy*; D011471:Prostatic Neoplasms / Q000628:therapy; D016032:Randomized Controlled Trials as Topic; D014481:United States